Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SCBGENOME(E) | +65.69% | −0.31% | +2.03% | −8.42% | +25.47% | +56.79% | +56.22% | +88.39% | −44.34% | −48.89% |
| BCARE | +14.91% | +1.99% | +5.09% | +8.23% | +8.14% | +17.30% | +23.16% | +33.14% | +7.17% | +6.72% |
| SCBRMGHC | +10.03% | +2.73% | +5.09% | +7.13% | +4.42% | +13.92% | +19.29% | +44.16% | +20.54% | +23.40% |
| SCBIHEALTH(SSF) | +9.97% | +2.52% | +6.75% | +8.51% | +11.52% | +21.09% | +13.77% | +19.97% | −50.75% | −54.88% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| SCBRMGHC | SCBIHEALTH(SSF) | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 9.70% | 9.59% |
 ABBVIE | 4.98% | 6.48% |
 AstraZeneca | 3.74% | 5.99% |
 Thermo Fisher | 3.38% | 4.12% |
 argenx | 2.47% | 3.12% |
 Merck & | 2.37% | 6.49% |
| Only in SCBRMGHC | ||
 Johnson & Johnson | 7.85% | N/A |
 Unitedhealth Group | 4.31% | N/A |
 Novartis | 2.76% | N/A |
 Roche | 2.70% | N/A |
| Only in SCBIHEALTH(SSF) | ||
 Gilead Sciences | N/A | 5.08% |
 Vertex Pharmaceuticals | N/A | 4.83% |
 Intuitive Surgical | N/A | 4.32% |
 Jazz Pharmaceuticals | N/A | 3.40% |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBGENOME(E) | +65.69% | 42.55% | 1.54 |
| BCARE | +14.91% | 15.93% | 0.94 |
| SCBRMGHC | +10.03% | 16.76% | 0.60 |
| SCBIHEALTH(SSF) | +9.97% | 17.40% | 0.57 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | SCBGENOME(E) | BCARE | SCBRMGHC | SCBIHEALTH(SSF) |
|---|---|---|---|---|
Fund details | ||||
| Fund size | 46.19 million | 4,712 million | 2,408 million | 88.18 million |
| Inception date | 20 Aug 2021 | 29 Aug 2007 | 6 Nov 2015 | 29 Jun 2021 |
| Master fund | กองทุน ARK Genomic Revolution ETF | Wellington Global Health Care Equity Fund | Janus Henderson Global Life Sciences Fund | BNP Paribas Funds Health Care Innovators |
| Dividend policy | Does not pay | Does not pay | Does not pay | Pays |
Risk and currency hedging | ||||
| Risk level | 7 | 7 | 7 | 7 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion | Almost fully hedged | Hedged at the manager's discretion |
| Share hedged | 57.68% | 47.41% | 100.58% | 82.39% |
Minimum purchase and redemption | ||||
| First purchase | 1 THB | 500 THB | 1,000 THB | 1,000 THB |
| Subsequent purchase | 1 THB | 500 THB | 1,000 THB | 1,000 THB |
| Redemption (amount) | 1 THB | No minimum | 1,000 THB | No minimum |
| Redemption (units) | No minimum | No minimum | No minimum | No minimum |
| Balance (amount) | 1 THB | No minimum | 1,000 THB | No minimum |
| Balance (units) | No minimum | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | 15:30 | 15:30 | 15:30 | 15:30 |
| Redeem before | 15:30 | 15:30 | 15:30 | 15:30 |
| Redemption paid | T+4 | T+4 | T+5 | T+4 |
